Talk:Oxybutynin

From Wikipedia, the free encyclopedia

	Oxybutynin is part of WikiProject Pharmacology, a project to improve all Pharmacology-related articles. If you would like to help improve this and other pharmacology articles, please join the project. All interested editors are welcome.
Start	This article has been rated as start-Class on the quality scale.
High	This article has been rated as high-importance for this Project's importance scale.

[edit] Oxybutynin transdermal patch

Kentera 3.9 mg / 24 hours, transdermal patch Kind regards: René--Crazy-Chemist 09:27, 11 September 2007 (UTC)

[edit] hyperhidrosis

What is YOUR supporting data for using the term 'possible' ? , instead of 'very effective' ?. I think you are splitting hairs with me Scott1976. Someone else could easily remove your connection of Oxybutynin with hyperhidrosis altogether, because Oxybutynin is not actually licenced yet for hyperhidrosis. Who says that YOUR wording is exactly correct, Scott1976 ?. Try45

Hey Scott1976 Are you going to respond to my comment??. Try45 —Preceding unsigned comment added by Try45 (talk • contribs) 13:12, 30 May 2008 (UTC)

Scott1976. I am waiting for your response. Try45 —Preceding unsigned comment added by Try45 (talk • contribs) 10:48, 8 June 2008 (UTC)

Actually, I'm not sure which wording would be best. That's why I've suggested discussion. The wording in the article appears to be based on the three cited referenced. I don't have access to the full text of the journal articles, only the abstracts. At least one of them seems to be a case study involving only one patient. If anyone has access to the full text, maybe we can see what the authors have concluded, and Wikipedia's wording should be consistent with that. What do you think? -- Ed (Edgar181) 13:35, 25 May 2008 (UTC)